JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.01% |
| 2 | Financials | 14.82% |
| 3 | Technology | 12.49% |
| 4 | Healthcare | 9.61% |
| 5 | Consumer Discretionary | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2151
Surgery Partners
SGRY
$1.73B
| $8.6M | ﹤0.01% |
710,515
+185,740
| +35% | +$1.78M |
2016 Q4
4 quarters
|
|
2152
Sally Beauty Holdings
SBH
$1.5B
| $8.6M | ﹤0.01% |
458,140
+65,071
| +17% | +$1.13M |
2015 Q4
8 quarters
|
|
2153
Invesco S&P Emerging Markets Low Volatility ETF
EELV
$409M
| $8.59M | ﹤0.01% |
338,962
+9,573
| +3% | +$236K |
2016 Q3
5 quarters
|
|
|
CORR
2154
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
| $8.58M | ﹤0.01% |
224,492
+185,842
| +481% | +$6.74M |
2016 Q2
6 quarters
|
|
|
BRFS
2155
DELISTED
BRF SA
BRFS
| $8.56M | ﹤0.01% |
760,562
-431,580
| -36% | -$5.51M |
2013 Q2
18 quarters
|
|
|
SRCLP
2156
DELISTED
Stericycle, Inc
SRCLP
| $8.56M | ﹤0.01% |
161,666
+14,946
| +10% | +$811K |
2015 Q3
9 quarters
|
|
2157
American Vanguard Corp
AVD
$51.6M
| $8.54M | ﹤0.01% |
434,834
+14,312
| +3% | +$296K |
2013 Q2
18 quarters
|
|
|
HES
2158
PUT
DELISTED
Hess
HES
| $8.54M | ﹤0.01% |
180,000
-150,000
| -45% | -$6.77M |
2016 Q2
6 quarters
|
|
|
BRS
2159
DELISTED
Bristow Group, Inc.
BRS
| $8.53M | ﹤0.01% |
632,930
+176,589
| +39% | +$2.09M |
2013 Q2
18 quarters
|
|
|
DCH
2160
Dauch Corp
DCH
$1.29B
| $8.51M | ﹤0.01% |
499,811
+10,469
| +2% | +$185K |
2015 Q1
11 quarters
|
|
|
GRP.U
2161
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $8.51M | ﹤0.01% |
225,411
+73,626
| +49% | +$2.91M |
2015 Q4
8 quarters
|
|
|
RPAI
2162
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $8.51M | ﹤0.01% |
632,781
+498,390
| +371% | +$6.48M |
2015 Q4
8 quarters
|
|
|
WCC
2163
WESCO International
WCC
$18.1B
| $8.5M | ﹤0.01% |
124,689
+33,548
| +37% | +$2.1M |
2013 Q2
18 quarters
|
|
2164
Pembina Pipeline
PBA
$26.3B
| $8.49M | ﹤0.01% |
234,663
+76,028
| +48% | +$2.63M |
2013 Q2
18 quarters
|
|
2165
Ameris Bancorp
ABCB
$5.38B
| $8.48M | ﹤0.01% |
176,022
+36,438
| +26% | +$1.76M |
2014 Q1
15 quarters
|
|
2166
Five Below
FIVE
$12.2B
| $8.48M | ﹤0.01% |
127,872
+122,603
| +2,327% | +$7.36M |
2015 Q3
9 quarters
|
|
2167
United Natural Foods
UNFI
$2.7B
| $8.47M | ﹤0.01% |
171,978
+18,476
| +12% | +$807K |
2015 Q4
8 quarters
|
|
2168
Novavax
NVAX
$1.75B
| $8.46M | ﹤0.01% |
341,283
+31,366
| +10% | +$765K |
2014 Q3
13 quarters
|
|
2169
Dell
DELL
$344B
| $8.43M | ﹤0.01% |
369,661
-3,225,871
| -90% | -$73.1M |
2016 Q3
5 quarters
|
|
2170
CALL
American Tower
AMT
$75B
| $8.43M | ﹤0.01% |
59,100
+4,100
| +7% | +$585K |
2017 Q1
3 quarters
|
|
|
LION
2171
DELISTED
Fidelity Southern Corporation
LION
| $8.43M | ﹤0.01% |
386,475
-13,683
| -3% | -$302K |
2013 Q2
18 quarters
|
|
2172
Teledyne Technologies
TDY
$28.4B
| $8.41M | ﹤0.01% |
46,438
+30,613
| +193% | +$5.38M |
2015 Q1
11 quarters
|
|
2173
Dorman Products
DORM
$3.65B
| $8.38M | ﹤0.01% |
137,117
+14,096
| +11% | +$956K |
2015 Q4
8 quarters
|
|
|
MPT
2174
Medical Properties Trust
MPT
$2.01B
| $8.38M | ﹤0.01% |
607,854
-33,987
| -5% | -$459K |
2013 Q2
18 quarters
|
|
|
FPRX
2175
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $8.37M | ﹤0.01% |
382,023
+96,660
| +34% | +$3.11M |
2015 Q4
8 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 812 new, 2,513 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 812 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.